The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...
The U.S. Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long ...
Eli Lilly’s LLY-1.65%decrease; red down pointing triangle experimental weight-loss drug retatrutide met the primary and key secondary endpoints in a trial, showing significant improvements in weight ...
Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep ...
GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy, Mounjaro and Zepbound, have gone ...
Americans want to lose weight but continuously fall short. As I've chronicled in this column year after year, weight-loss and related goals like exercising more and eating better are among the top New ...
Share on Pinterest What should you eat for breakfast to lose weight? A new study investigates. Image credit: Nadine Greeff/Stocksy New research suggests that, particularly for those trying to lose ...
Intermittent fasting has become a buzzword in nutrition circles, with many people looking to it as a way to lose weight or improve their health. But new research from the Cochrane Collaboration shows ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...
Share on Pinterest A new review of evidence found that intermittent fasting is no better than other dietary patterns for weight loss. yunxi xie/Getty Images Researchers report that intermittent ...
Researchers in Australia are raising flags about GLP-1 weight-loss medications potentially raising the risk of a rare disease. Scurvy — historically called a "pirate disease" due to long voyages at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results